Skip to main content
. 2021 May 4;12:633904. doi: 10.3389/fendo.2021.633904

Table 5.

Univariate analysis between patients with and without improvement in erectile function after treatment.

Improvement group Non-improvement group P value
GH normalization after treatment (%) 72.7% 43.8% 0.239
Post-GH (ng/ml) 0.44 [0.15-1.03] 2.02 [0.21-5.27] 0.236
GHn normalization after treatment (%) 88.9% 46.7% 0.039*
Post-GHn (ng/ml) 0.07 [0.03-0.12] 1.32 [0.09-3.60] 0.048*
IGF-1 normalization after treatment (%) 72.7% 25.0% 0.040*
Post-IGF index 1.03 ± 0.38 1.66 ± 0.95 0.049*
Testosterone normalization after treatment (%) 63.6% 43.8% 0.440
Post-Testosterone (nmol/L) 10.56 ± 5.36 9.07 ± 4.43 0.437